3-month results from the CLARITY Study Show the NEUROMARK® System provides safe and effective treatment for patients with Chronic Rhinitis.
Explore 12-month safety and efficacy outcomes for treating Chronic Rhinitis with NEUROMARK®.
PARAGON 6-month Study data shows NEUROMARK® treatment benefits allergic and nonallergic rhinitis patients.
A successful round of fundraising has brought over €9 million to Neurent Medical as they develop a breakthrough therapy for Chronic Rhinitis
After closing a $25M Series B funding round, Neurent Medical prepares for commercialization of revolutionary in-office therapy.
Neurent Medical's expanded leadership team brings deep medical device and ENT-specific experience to the growing company.
